Ettrich, Thomas J. https://orcid.org/0000-0002-7654-2442
Seufferlein, Thomas
Funding for this research was provided by:
Universität Ulm
Article History
Accepted: 1 July 2021
First Online: 19 October 2021
Change Date: 7 March 2022
Change Type: Update
Change Details: The original version of this paper was updated to add the missing compact agreement Open Access funding note.
Declarations
:
: Thomas J. Ettrich has received compensation from Servier and AstraZeneca for service on advisory boards, and has received travel support from Celgene. Thomas Seufferlein has received research funding from Celgene, and has received speaker's honoraria and compensation for service on advisory boards from Servier and Celgene.